{"result": "(\"entity\"<|>PACIENTES<|>PERSON<|>Los pacientes con hiperplasia suprarrenal congénita son aquellos que sufren de un trastorno endocrino que afecta la producción de hormonas en las glándulas suprarrenales.)\n##\n(\"entity\"<|>DEXAMETASONA<|>ORGANIZATION<|>La dexametasona es un glucocorticoide que no se inactiva a nivel placentario y se utiliza en el tratamiento de ciertas condiciones médicas.)\n##\n(\"entity\"<|>PARTO<|>EVENT<|>El parto es el proceso de dar a luz, durante el cual se deben utilizar dosis de estrés de hidrocortisona en pacientes con riesgo de insuficiencia suprarrenal.)\n##\n(\"entity\"<|>GENOTIPO<|>PERSON<|>El genotipo de la pareja es importante para definir el riesgo de transmisión de la hiperplasia suprarrenal congénita a la descendencia.)\n##\n(\"relationship\"<|>PACIENTES<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>Los pacientes son aquellos que padecen hiperplasia suprarrenal congénita y requieren tratamiento<|>8)\n##\n(\"relationship\"<|>PARTO<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>Durante el parto, se deben tomar precauciones especiales para pacientes con hiperplasia suprarrenal congénita<|>6)\n##\n(\"relationship\"<|>GENOTIPO<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>El conocimiento del genotipo de la pareja es crucial para evaluar el riesgo de hiperplasia suprarrenal congénita en la descendencia<|>7)\n##\n(\"relationship\"<|>DEXAMETASONA<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>La dexametasona no debe ser administrada a pacientes con hiperplasia suprarrenal congénita a menos que haya riesgo de un feto femenino afectado<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: responsable de la síntesis de los mineralocorticoides,                                                (glucocorticoides que no atraviesan la placenta) para aquellas mujeres con hiperplasia su-\n         es más resistente al efecto adrenolítico del mitotano.                                                                                     prarrenal congénita no clásica por déficit de 21-hidroxilasa que desean gestación y presen-\n                                                                                                                                                    tan infertilidad o abortos previos.\n         Referencias:\n         • Lacroix A, Hammer GD. Treatment of adrenocortical carcinoma. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com.\n           Literature review current through: Apr. 2019.\n         • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n           of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 490-555.\n\n\n\n298                                                                                                                                                                                                                                                      299\n---\n                                                                                                                                                                                                                             SUPRARRENALES                                         5\n\n\n\n         En relación con la gestación en pacientes con formas clásicas de hiperplasia suprarrenal                                                  Aproximadamente, dos tercios de los pacientes con hiperplasia suprarrenal congénita por\n         congénita por déficit de 21-hidroxilasa, debe continuarse el tratamiento previo con gluco-                                                déficit de 21-hidroxilasa son portadores heterocigotos de mutaciones graves y leves so-\n         corticoides y mineralocorticoides. No se debe administrar dexametasona (no se inactiva                                                    bre los diferentes alelos. Así, los pacientes con deseos de fertilidad deberían tener un estu-\n         a  nivel    placentario), excepto           si hay     riesgo de      feto   femenino afectado             (padre también                 dio genético realizado. El riesgo de déficit grave de 21-hidroxilasa en el hijo de un paciente\n         afectado o portador). Durante el parto se deben utilizar, como en cualquier paciente con                                                  con una forma no clásica es del 2,5%, mientras que el riesgo de una forma no clásica sería\n         riesgo de insuficiencia suprarrenal, dosis de estrés de hidrocortisona.                                                                   del 25% por lo que el conocimiento del genotipo de la pareja es de                               gran importancia para\n         Referencias:                                                                                                                              definir mejor ese riesgo.\n         • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, et al. Harrison      Referencias:\n           Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.                                     • Arlt W. Trastornos de la corteza suprarrenal. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, et al. Harrison\n         • Auchus RJ. Treatment of classic congenital adrenal hyperplasia due to 21-hydroxilasa deficiency in adults. UpToDate. Waltham, MA:         Principios de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2309-29.\n           UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.                                                   • Auchus RJ. Treatment of classic congenital adrenal hyperplasia due to 21-hydroxilasa deficiency in adults. UpToDate. Waltham,\n         • Rodríguez Arnao MD, Sanz Fernández M, Rodríguez Sánchez A. Hiperplasia adrenal congénita. Manual de Endocrinología y Nutrición.           MA: UpToDate Inc. https://www.uptodate.com. Literature review current through: Apr. 2019.\n           Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).                                                   • Rodríguez Arnao MD, Sanz Fernández M, Rodríguez Sánchez A. Hiperplasia adrenal congénita. Manual de Endocrinología y Nutrición.\n         • Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxilasa        Disponible en: https://manual.seen.es (última modificación: 25 de noviembre de 2015).\n           deficiency: an Endocrine Society Practice Guideline.                                                                                    • Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxilasa\n           J Clin Endocrinol Metab. 2018;103:4043-88.                                                                                                deficiency: an Endocrine Society Practice Guideline. J Clin Endocrinol Metab. 2018;103:4043-88.\n                                                                                                                                                   • Steward PM, Newell-Price JDC. The adrenal cortex. En: Melmed S,\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>EVENT<|>Hiperplasia suprarrenal congénita es un trastorno endocrino que afecta la producción de hormonas en las glándulas suprarrenales, especialmente en mujeres que desean gestación y presentan infertilidad o abortos previos.)\n##\n(\"entity\"<|>GLUCOCORTICOIDES<|>ORGANIZATION<|>Los glucocorticoides son hormonas esteroides producidas por la corteza adrenal que son esenciales para el metabolismo y la respuesta al estrés.)\n##\n(\"entity\"<|>MINERALOCORTICOIDES<|>ORGANIZATION<|>Los mineralocorticoides son hormonas esteroides que regulan el equilibrio de agua y electrolitos en el cuerpo, producidas por la corteza adrenal.)\n##\n(\"entity\"<|>21-HIDROXILASA<|>PERSON<|>La 21-hidroxilasa es una enzima crucial en la síntesis de hormonas esteroides en las glándulas suprarrenales, y su deficiencia causa hiperplasia suprarrenal congénita.)\n##\n(\"entity\"<|>UPTODATE<|>ORGANIZATION<|>UpToDate es una base de datos médica que proporciona información actualizada sobre tratamientos y condiciones médicas, utilizada por profesionales de la salud.)\n##\n(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison Principios de Medicina Interna es un texto médico de referencia que cubre una amplia gama de temas en medicina interna.)\n##\n(\"relationship\"<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>21-HIDROXILASA<|>La deficiencia de 21-hidroxilasa es la causa principal de la hiperplasia suprarrenal congénita<|>8)\n##\n(\"relationship\"<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>GLUCOCORTICOIDES<|>El tratamiento de la hiperplasia suprarrenal congénita incluye la administración de glucocorticoides para manejar los síntomas<|>7)\n##\n(\"relationship\"<|>HIPERPLASIA SUPRARRENAL CONGÉNITA<|>MINERALOCORTICOIDES<|>El tratamiento de la hiperplasia suprarrenal congénita también requiere el uso de mineralocorticoides para el equilibrio electrolítico<|>7)\n##\n(\"relationship\"<|>UPTODATE<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>Ambas son fuentes de referencia médica que proporcionan información sobre condiciones como la hiperplasia suprarrenal congénita<|>5)\n<|COMPLETE|>"}]}